Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$836M |
| 2 |
Microsoft
MSFT
|
+$748M |
| 3 |
Cigna
CI
|
+$560M |
| 4 |
3M
MMM
|
+$558M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$535M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$568M |
| 2 |
Zoom
ZM
|
+$557M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$516M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$479M |
| 5 |
Unity
U
|
+$476M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.72% |
| 2 | Healthcare | 11.35% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Communication Services | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3526
JFrog
FROG
$11.6B
| $5.75M | ﹤0.01% |
260,348
-526,762
| -67% | -$11.7M |
|
3527
Orthofix Medical
OFIX
$421M
| $5.75M | ﹤0.01% |
300,938
+140,042
| +87% | +$3.15M |
|
|
VNET
3528
VNET Group
VNET
$2.16B
| $5.73M | ﹤0.01% |
1,042,264
-546,306
| -34% | -$2.88M |
|
3529
ADMA Biologics
ADMA
$2.12B
| $5.73M | ﹤0.01% |
2,357,621
+1,498,858
| +175% | +$3.6M |
|
3530
AtriCure
ATRC
$2.25B
| $5.73M | ﹤0.01% |
146,518
+17,147
| +13% | +$784K |
|
3531
Scansource
SCSC
$1.08B
| $5.73M | ﹤0.01% |
216,837
-46,449
| -18% | -$1.4M |
|
3532
Xenon Pharmaceuticals
XENE
$6.03B
| $5.72M | ﹤0.01% |
158,452
-839,620
| -84% | -$30.2M |
|
3533
Celldex Therapeutics
CLDX
$3.29B
| $5.72M | ﹤0.01% |
203,383
-278,644
| -58% | -$8.54M |
|
|
IBHD
3534
DELISTED
iShares iBonds 2024 Term High Yield and Income ETF
IBHD
| $5.71M | ﹤0.01% |
256,301
+85,825
| +50% | +$1.95M |
|
3535
B2Gold
BTG
$6.79B
| $5.69M | ﹤0.01% |
1,767,556
-1,393,071
| -44% | -$4.59M |
|
3536
GH Research
GHRS
$2.02B
| $5.69M | ﹤0.01% |
489,336
+10,717
| +2% | +$135K |
|
3537
Columbia Financial
CLBK
$1.23B
| $5.68M | ﹤0.01% |
268,889
-15,464
| -5% | -$334K |
|
|
FNI
3538
DELISTED
First Trust Chindia ETF
FNI
| $5.68M | ﹤0.01% |
162,711
-434
| -0.3% | -$16.8K |
|
3539
Community Trust Bancorp
CTBI
$1.43B
| $5.67M | ﹤0.01% |
139,953
+9,040
| +7% | +$384K |
|
3540
Hawkins
HWKN
$2.74B
| $5.66M | ﹤0.01% |
145,175
-8,908
| -6% | -$345K |
|
3541
Banco de Chile
BCH
$20.6B
| $5.65M | ﹤0.01% |
319,963
+17,100
| +6% | +$316K |
|
|
PDM
3542
Piedmont Realty Trust
PDM
$1.19B
| $5.65M | ﹤0.01% |
535,195
-43,062
| -7% | -$541K |
|
3543
CEVA Inc
CEVA
$937M
| $5.64M | ﹤0.01% |
215,123
+10,656
| +5% | +$342K |
|
3544
Grupo Aeroportuario Centro Norte
OMAB
$4.99B
| $5.64M | ﹤0.01% |
112,468
-8,396
| -7% | -$440K |
|
3545
Rhythm Pharmaceuticals
RYTM
$7.95B
| $5.64M | ﹤0.01% |
230,197
-200,550
| -47% | -$3.73M |
|
3546
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.58B
| $5.64M | ﹤0.01% |
61,784
-4,159
| -6% | -$401K |
|
|
RUTH
3547
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $5.63M | ﹤0.01% |
333,830
+18,363
| +6% | +$325K |
|
3548
TriMas Corp
TRS
$1.4B
| $5.62M | ﹤0.01% |
224,038
+14,965
| +7% | +$412K |
|
3549
Horizon Bancorp
HBNC
$1.06B
| $5.61M | ﹤0.01% |
312,558
+18,229
| +6% | +$343K |
|
|
KDNY
3550
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $5.61M | ﹤0.01% |
285,458
+54,724
| +24% | +$1.1M |
|
Similar funds
Morgan Stanley's Q3 2022 Portfolio in Review
As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
- Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
- Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
- Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
- Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
- Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.
Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.